DiaMedica Therapeutics Inc. (DMAC)

NASDAQ: DMAC · IEX Real-Time Price · USD

2.600

+0.070 (2.77%)

At close: Apr 26, 2024, 3:57 PM

2.580

-0.020 (-0.77%)

After-hours: Apr 26, 2024, 4:00 PM EDT

DiaMedica Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018
Market Capitalization	98	108	42	99	190	58	34
Market Cap Growth	-	157.97%	-57.63%	-48.10%	226.30%	69.03%	-
Enterprise Value	45	55	9	54	163	50	18
PE Ratio	-5.58	-5.58	-3.05	-7.23	-15.45	-5.47	-6.01
PS Ratio	-	-	-	-	-	-	68.90
PB Ratio	1.91	2.11	1.31	2.24	7.30	7.65	2.02
P/FCF Ratio	-5.75	-5.75	-3.60	-8.04	-20.62	-6.41	-6.00
P/OCF Ratio	-5.76	-5.76	-3.63	-8.05	-20.69	-6.40	-6.05
EV/Sales Ratio	-	-	-	-	-	-	35.30
EV/EBITDA Ratio	-2.89	-2.89	-0.64	-3.96	-13.33	-4.78	-3.13
EV/EBIT Ratio	-2.87	-2.87	-0.64	-3.93	-13.25	-4.75	-3.12
EV/FCF Ratio	-2.95	-2.95	-0.75	-4.36	-17.64	-5.55	-3.07
Debt / Equity Ratio	0.01	0.01	0.01	0.00	0.00	0.02	0.00
Debt / EBITDA Ratio	-0.02	-0.02	-0.03	0.00	-0.01	-0.02	0.00
Debt / FCF Ratio	-0.02	-0.02	-0.04	0.00	-0.01	-0.02	0.00
Quick Ratio	19.12	19.12	15.49	29.69	13.74	6.67	13.58
Current Ratio	19.27	19.27	15.61	29.82	13.77	6.70	13.87
Asset Turnover	0	0	0	0	0	0	0.05
Return on Equity (ROE)	-39.90%	-39.90%	-37.70%	-40.60%	-61.20%	-99.20%	-64.30%
Return on Assets (ROA)	-37.70%	-37.70%	-35.80%	-38.90%	-57.00%	-88.00%	-56.90%
Return on Capital (ROIC)	-41.33%	-41.33%	-43.35%	-30.96%	-48.60%	-148.72%	-39.66%
Earnings Yield	-19.79%	-17.91%	-32.79%	-13.83%	-6.47%	-18.28%	-16.64%
FCF Yield	-19.22%	-17.40%	-27.74%	-12.44%	-4.85%	-15.61%	-16.68%
Buyback Yield / Dilution	-23.16%	-23.16%	-27.29%	-32.48%	-30.80%	-54.81%	-30.45%
Total Shareholder Return	-23.16%	-23.16%	-27.29%	-32.48%	-30.80%	-54.81%	-30.45%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).